$39.41
+3.95 (+11.14%)
OMCL News3 articles
Market Update: Bapcor Shares Fall on Lowered EBITDA Forecast
Bapcor shares fell 18% after lowering FY2026 EBITDA forecast to $144-150 million amid cost pressures. Nvidia earnings loom, Indian shares decline on oil surge, and Hubbbell, Welltower show strength.
Omnicell Shares Jump 17.5% on Q1 Beat, Raised 2026 Guidance
Omnicell shares jumped 17.5% after Q1 results topped estimates and the company raised its 2026 profit outlook, citing strong demand for its Titan XT system.
Hims & Hers Soars on FDA Catalyst as Omnicell Underperforms
Hims & Hers Health shares surged nearly 9% Monday, extending a strong weekly gain ahead of its May earnings report and a key FDA meeting on peptides. Omnicell reported mixed Q4 results with a net loss.